Trial of Rituximab for Graves' Ophthalmopathy

Clinical trial NCT00595335 · COMPLETED

Trial details

NCT number: NCT00595335
Sponsor: Rebecca Bahn
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Thyroid-associated Ophthalmopathy

Start date: 2008-04-01
Primary completion: 2013-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.